Macquarie upgraded Core Scientific to outperform from neutral and hiked its price target on the stock to $34 after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback